Poll finds public backs Democrats' healthcare plan, drug price negotiations
Americans overwhelmingly support negotiations between the federal government and prescription drug companies to get better deals for the Medicare drug benefit program, according to results of a new poll conducted by the Kaiser Family Foundation.Some 85% of those polled said they favored such negotiations. House Democrats say they plan to use their majority control of the next Congress to repeal a provision in the 2003 Medicare drug benefit law that prevents the government from engaging in drug price negotiations.
Wielding negotiating power to achieve lower drug prices should ultimately take pressure off of state Medicaid budgets, advocates say. In turn, that should ease pressure to cut provider reimbursements down the road, they add.